KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Bausch Health Companies (BHC) R&D In Process (2016 - 2019)

Bausch Health Companies (BHC) has disclosed R&D In Process for 9 consecutive years, with $1.0 million as the latest value for Q1 2019.

  • Quarterly R&D In Process changed 0.0% to $1.0 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was -$3.0 million through Mar 2019, down 123.08% year-over-year, with the annual reading at $1.0 million for FY2018, 80.0% down from the prior year.
  • R&D In Process hit $1.0 million in Q1 2019 for Bausch Health Companies, roughly flat from $1.0 million in the prior quarter.
  • In the past five years, R&D In Process ranged from a high of $95.8 million in Q3 2015 to a low of -$5.0 million in Q3 2016.
  • Historically, R&D In Process has averaged $18.0 million across 4 years, with a median of $1.0 million in 2018.
  • Biggest five-year swings in R&D In Process: crashed 110.5% in 2015 and later changed 0.0% in 2019.
  • Year by year, R&D In Process stood at -$2.1 million in 2015, then crashed by 138.1% to -$5.0 million in 2016, then skyrocketed by 120.0% to $1.0 million in 2018, then changed by 0.0% to $1.0 million in 2019.
  • Business Quant data shows R&D In Process for BHC at $1.0 million in Q1 2019, $1.0 million in Q1 2018, and -$5.0 million in Q3 2016.